Oral Intake of EPA:DHA 6:1 by Middle-Aged Rats for One Week Improves Age-Related Endothelial Dysfunction in Both the Femoral Artery and Vein: Role of Cyclooxygenases

scientific article published on 30 January 2020

Oral Intake of EPA:DHA 6:1 by Middle-Aged Rats for One Week Improves Age-Related Endothelial Dysfunction in Both the Femoral Artery and Vein: Role of Cyclooxygenases is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3390/IJMS21030920
P932PMC publication ID7037507
P698PubMed publication ID32019237

P50authorSin-Hee ParkQ87995648
Cyril AugerQ89529698
P2093author name stringFlorence Toti
Valérie B Schini-Kerth
Sonia Khemais-Benkhiat
Brigitte Pollet
Dominique Stephan
Sébastien Gaertner
Muhammad A Farooq
Sophie Schrevens
Zahid R Niazi
P2860cites workHeart Disease and Stroke Statistics--2015 Update: A Report From the American Heart AssociationQ22241921
Omega-3 fatty acids for intermittent claudicationQ24201333
Omega 3 fatty acids for prevention and treatment of cardiovascular diseaseQ24245810
PUFAs: Structures, Metabolism and FunctionsQ26771687
The impact of omega-3 polyunsaturated fatty acid supplementation on the incidence of cardiovascular events and complications in peripheral arterial disease: a systematic review and meta-analysisQ26852020
Omega-3 polyunsaturated fatty acids and cardiovascular diseasesQ27863409
Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammationQ28210028
Dose translation from animal to human studies revisitedQ29618049
A Meta-Analysis of Randomized Controlled Trials and Prospective Cohort Studies of Eicosapentaenoic and Docosahexaenoic Long-Chain Omega-3 Fatty Acids and Coronary Heart Disease RiskQ30239801
Eicosapentaenoic acid (EPA) induces Ca(2+)-independent activation and translocation of endothelial nitric oxide synthase and endothelium-dependent vasorelaxationQ31860738
Does supplementation of diet with 'fish oil' reduce blood pressure? A meta-analysis of controlled clinical trials.Q52394816
Categorization of patients as having provoked or unprovoked venous thromboembolism: guidance from the SSC of ISTHQ56964516
Dietary omega-3 alpha-linolenic acid does not prevent venous thrombosis in miceQ57618798
Cardiovascular Risk Reduction with Icosapent Ethyl for HypertriglyceridemiaQ58480971
Differential vasoconstrictor potencies of free fatty acids in the lung vasculature: 2-versus 3-series prostanoid generationQ60364517
Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort studyQ73836575
Incidence and mortality of venous thrombosis: a population-based studyQ79969827
Healthy effect of different proportions of marine ω-3 PUFAs EPA and DHA supplementation in Wistar rats: Lipidomic biomarkers of oxidative stress and inflammationQ86034497
Association between hospitalization for acute medical illness and VTE risk: A lower efficacy of thromboprophylaxis in elderly patients? Results from the EDITH case-control studyQ88383803
Marine OMEGA-3 fatty acids in the prevention of cardiovascular diseaseQ89112226
EPA:DHA 6:1 is a superior omega-3 PUFAs formulation attenuating platelets-induced contractile responses in porcine coronary and human internal mammary artery by targeting the serotonin pathway via an increased endothelial formation of nitric oxideQ92411091
Reduction in First and Total Ischemic Events With Icosapent Ethyl Across Baseline Triglyceride TertilesQ92790940
Long-chain omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and blood pressure: a meta-analysis of randomized controlled trialsQ33745366
The importance of the ratio of omega-6/omega-3 essential fatty acidsQ33962634
Redox-sensitive induction of Src/PI3-kinase/Akt and MAPKs pathways activate eNOS in response to EPA:DHA 6:1Q34061779
Risk assessment for recurrent venous thrombosisQ34153343
Long chain omega-3 fatty acids and cardiovascular disease: a systematic review.Q34275370
Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel ReportQ34513594
Cyclooxygenase-2 generates anti-inflammatory mediators from omega-3 fatty acidsQ34800981
The epidemiology of venous thromboembolism.Q35157791
Omega-3 fatty acids and inflammatory processesQ35670928
Age-related decline in prostacyclin synthesis by human aortic endothelial cells. Qualitative and quantitative analysisQ35830481
eNOS uncoupling and endothelial dysfunction in aged vesselsQ37431006
Omega-3 PUFA derived anti-inflammatory lipid mediator resolvin E1.Q37593747
Age-related alterations in endothelial function of femoral artery in young SHR and WKY rats.Q37687931
Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control studyQ38497226
Use of supplemental long-chain omega-3 fatty acids and risk for cardiac death: An updated meta-analysis and review of research gapsQ38619530
Venous thromboembolism in the elderly: A narrative review.Q38678220
Aging decreases the production of PGI2 in rat aortic endothelial cellsQ42462845
The Swiss cohort of elderly patients with venous thromboembolism (SWITCO65+): rationale and methodologyQ42684909
Vascular bed heterogeneity in age-related endothelial dysfunction with respect to NO and eicosanoidsQ43264532
Resolvin D1 reverses reactivity and Ca2+ sensitivity induced by ET-1, TNF-α, and IL-6 in the human pulmonary artery.Q44733587
Gene expression changes of prostanoid synthases in endothelial cells and prostanoid receptors in vascular smooth muscle cells caused by aging and hypertensionQ46868364
EPA:DHA 6:1 prevents angiotensin II-induced hypertension and endothelial dysfunction in rats: role of NADPH oxidase- and COX-derived oxidative stress.Q47845782
Omega-3 polyunsaturated fatty acids reduce vascular tone and inflammation in human saphenous vein.Q47909305
Deletion of PPAR gamma in alveolar macrophages is associated with a Th-1 pulmonary inflammatory responseQ47976088
Increased risk and severity of unprovoked venous thromboembolism with clustering cardiovascular risk factors for atherosclerosis: Results of the REMOTEV registryQ49702848
Omega-3 fatty acids predict recurrent venous thromboembolism or total mortality in elderly patients with acute venous thromboembolism.Q50129776
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue3
P577publication date2020-01-30
P1433published inInternational Journal of Molecular SciencesQ3153277
P1476titleOral Intake of EPA:DHA 6:1 by Middle-Aged Rats for One Week Improves Age-Related Endothelial Dysfunction in Both the Femoral Artery and Vein: Role of Cyclooxygenases
P478volume21

Search more.